サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1428124

mRNA (メッセンジャーリボ核酸) 合成原料の世界市場レポート (2024年)

Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Global Market Report 2024
出版日: 受注後更新 | 発行: The Business Research Company | ページ情報: 英文 175 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
mRNA (メッセンジャーリボ核酸) 合成原料の世界市場レポート (2024年)
出版日: 受注後更新
発行: The Business Research Company
ページ情報: 英文 175 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 目次
概要

mRNA合成原料の市場規模は、今後数年間で着実な成長が見込まれています。 2.9%の年間複合成長率 (CAGR) で成長し、2028年には33億9,000万米ドルに達すると予想されます。予測期間中の市場成長は、サプライチェーン効率の強化、商業活動の増加、市場範囲の拡大、バイオテクノロジーと医薬品への投資の拡大、規制上の支援と承認の強化、および広範な治療法の進歩によって推進されます。この時期に予想される主要な動向には、新たな業界参加者の台頭、品質管理と標準化の重視の強化、知的財産権とライセンス契約への注力、世界なアクセスと公平性の追求、環境的に持続可能で拡張可能な製造慣行への顕著な移行が含まれます。

mRNA合成原料市場は、がんや慢性疾患の発生率の増加により成長すると予想されています。体の他の部分に広がる可能性のある異常な細胞の制御されない発生を特徴とするがんや、1年以上持続し継続的な治療が必要な慢性疾患は、mRNA合成原料の需要を生み出します。これらの材料は、創薬、ワクチン開発、RNAベースの治療薬の製造において重要な役割を果たし、免疫原性の向上、効率の向上、製造時間の短縮などの利点をもたらします。たとえば、2022年 4月に米国がん協会は、米国での新たながん症例数が192万件であると報告し、2021年の189万件から増加していることを示しています。さらに、全米高齢者評議会の統計では、65歳以上の個人の約80%が少なくとも1つの慢性疾患を経験しており、68%が2つ以上の慢性疾患を抱えています。したがって、がんや慢性疾患の発生率の増加は、mRNA合成原料市場の重要な促進要因となっています。

mRNA技術を支援する政府の取り組みにより、mRNA合成原料市場の成長を推進する態勢が整っています。これらの取り組みには、mRNA技術の研究・開発・利用促進のための政府機関による取り組み調整・プログラム・政策・財政的支援が含まれます。 このような政府の支援は、資金、インフラ、規制上の支援、および国際的な協力機会を提供することにより、mRNA合成原料市場に有利な環境を作り出します。 2023年2月の時点で、BMJは、米国政府がパンデミック後のmRNA COVID-19ワクチンに319億米ドルを投資したと報じました。財政的支援にもかかわらず、Pfizer-BioNTechやModernaなどの企業のmRNAワクチンのコストが、ワクチン価格の進化を反映して時間の経過とともに増加していることは注目に値します。具体的には、Pfizer-BioNTechのワクチンの1回分あたりの価格は、2020年の19.50米ドルから2022年の二価追加免疫の30.48米ドルに上昇したが、Modernaのコストは2020年の1回分あたり15.25米ドルから2022年には26.36米ドルに上昇しました。したがって、mRNA技術に対する政府の取り組みが、mRNA合成原料市場の成長を促進する重要な役割を果たします。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

  • 高インフレが市場に与える影響
  • ウクライナ・ロシア戦争が市場に与える影響
  • COVID-19による市場への影響

第5章 世界の市場規模と成長

  • 世界のmRNA合成原料市場の促進要因と抑制要因
    • 市場の促進要因
    • 市場の抑制要因
  • 世界のmRNA合成原料の市場規模・成長率、実績、2018年～2023年
  • 世界のmRNA合成原料の市場規模・成長率、予測、2023年～2028年、2033年

第6章 市場セグメンテーション

  • 世界のmRNA合成原料市場、種類別セグメンテーション、実績・予測、2018年～2023年、2023～2028年、2033年
  • キャッピング剤
  • ヌクレオチド
  • プラスミドDNA
  • その他の種類
  • 世界のmRNA合成原料市場、用途別セグメンテーション、実績・予測、2018年～2023年、2023～2028年、2033年
  • 治療薬の製造
  • ワクチンの生産
  • その他の用途
  • 世界のmRNA合成原料市場、エンドユーザー別のセグメンテーション、実績・予測、2018年～2023年、2023～2028年、2033年
  • バイオテクノロジー企業
  • 製薬企業
  • 研究・学術機関
  • その他のエンドユーザー

第7章 地域および国の分析

  • 世界のmRNA合成原料市場、地域別、実績・予測、2018年～2023年、2023～2028年、2033年
  • 世界のmRNA合成原料市場、国別、実績・予測、2018年～2023年、2023～2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

  • mRNA合成原料市場の競合情勢
  • mRNA合成原料企業のプロファイル
    • Pfizer Inc.
    • F. Hoffmann-La Roche AG
    • Thermo Fisher Scientific Inc.
    • Moderna Inc
    • Agilent Technologies Inc.

第31章 その他の大手および革新的な企業

  • Lonza Group Ltd.
  • Eurofins Scientific
  • Bio-Rad Laboratories Inc.
  • Qiagen NV
  • Maravai LifeSciences
  • Takara Bio Inc.
  • GenScript Biotech Corporation
  • Promega Corporation
  • Abcam plc
  • BioLegend Inc.
  • Integrated DNA Technologies Inc.
  • Sino Biological Inc.
  • CureVac NV
  • LGC Biosearch Technologies
  • Enzo Biochem Inc

第32章 競合ベンチマーキング

第33章 競合ダッシュボード

第34章 主要な合併と買収

第35章 将来の見通しと可能性の分析

第36章 付録

目次
Product Code: r13968

Messenger ribonucleic acid (mRNA) synthesis raw materials comprise ribonuclear components crucial for the precise and efficient creation of mRNA molecules in in-vitro transcription procedures, facilitating the production of functional synthetic RNAs. These materials play a pivotal role in generating mRNA vaccines that trigger the body's immune system to produce a defense response against specific antigens, thereby enhancing overall immune capacity.

Key components of mRNA synthesis raw materials encompass capping agents, nucleotides, plasmid DNA, among others. Capping agents, for instance, are amphiphilic molecules featuring a polar head group and a non-polar hydrocarbon tail. These agents are utilized in introducing modified cap structures to mRNA molecules during synthesis, imparting stability and protection to the mRNA. This enhances translation efficiency and fortifies the mRNA against degradation. These materials find diverse applications in therapeutics and vaccine production and are commonly employed by biotechnology firms, pharmaceutical companies, research institutions, and similar entities.

The mRNA synthesis raw materials market research report is one of a series of new reports from The Business Research Company that provides mRNA synthesis raw materials market statistics, including mRNA synthesis raw materials industry global market size, regional shares, competitors with mRNA synthesis raw materials market share, detailed mRNA synthesis raw materials market segments, market trends, and opportunities, and any further data you may need to thrive in the mRNA synthesis raw materials industry. This mRNA synthesis raw materials market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The mrna synthesis raw materials market size has grown steadily in recent years. It will grow from $2.94 billion in 2023 to $3.02 billion in 2024 at a compound annual growth rate (CAGR) of 2.8%. The growth observed in the historical period can be attributed to several factors, including notable advancements in biomedical research, a heightened interest in vaccines and therapeutic developments, increased demand for personalized medicine, focus on outbreak preparedness and response measures, and the overall expansion of the biotechnology industry.

The mrna synthesis raw materials market size is expected to see steady growth in the next few years. It will grow to $3.39 billion in 2028 at a compound annual growth rate (CAGR) of 2.9%. The projected growth during the forecasted period is driven by enhancements in supply chain efficiency, increased commercial activities, expanded market reach, amplified investments in biotechnology and pharmaceuticals, bolstered regulatory backing and approvals, and broader therapeutic advancements. Key trends anticipated in this period encompass the rise of new industry participants, heightened emphasis on quality control and standardization, focus on intellectual property rights and licensing, pursuit of global accessibility and fairness, and a notable shift towards environmentally sustainable and scalable manufacturing practices.

The mRNA synthesis raw materials market is anticipated to witness growth, driven by the increasing incidence of cancer and chronic disorders. Cancer, characterized by the uncontrolled development of aberrant cells that can spread to other parts of the body, and chronic disorders, persisting for a year or longer and requiring ongoing medical attention, create a demand for mRNA synthesis raw materials. These materials play a crucial role in drug discovery, vaccine development, and the manufacturing of RNA-based therapeutics, offering advantages such as improved immunogenicity, higher efficiency, and a short production time. For example, in April 2022, the American Cancer Society reported 1.92 million new cancer cases in the U.S., indicating a rise from 1.89 million cases in 2021. Additionally, the National Council on Aging's statistics revealed that about 80% of individuals aged 65 and older in the United States will experience at least one chronic ailment, with 68% having two or more. Consequently, the growing incidence of cancer and chronic disorders is a significant driver for the mRNA synthesis raw materials market.

Government initiatives supporting mRNA technology are poised to drive the growth of the mRNA synthesis raw materials market. These initiatives encompass coordinated efforts, programs, policies, and financial backing by governmental entities to promote research, development, and application of Messenger RNA (mRNA) technology. Such government support creates a conducive environment for the mRNA synthesis raw materials market by providing funding, infrastructure, regulatory backing, and opportunities for global collaboration. As of February 2023, The BMJ reported that the US government has invested $31.9 billion in mRNA COVID-19 vaccines post-pandemic. Despite financial support, it is noteworthy that the costs for mRNA vaccines from companies such as Pfizer-BioNTech and Moderna have increased over time, reflecting the evolving landscape of vaccine pricing. Specifically, the pricing per dose for Pfizer-BioNTech's vaccine increased from $19.50 in 2020 to $30.48 for the bivalent booster in 2022, while Moderna's costs rose from $15.25 per dose in 2020 to $26.36 in 2022. Hence, government initiatives for mRNA technology play a pivotal role in propelling the growth of the mRNA synthesis raw materials market.

The mRNA synthesis raw materials market is witnessing a notable trend with the increasing emphasis on product innovations. Key players in this market are strategically focusing on the development of innovative products to enhance their market positioning. An illustrative example is Thermo Fisher Scientific, a prominent US-based company specializing in instrumentation, reagents, consumables, and software services. In September 2022, the company introduced Dynabeads Solutions, a revolutionary bead designed for scaling GMP-grade synthesis and purification of mRNA for vaccine development. The Dynabeads Streptavidin for In Vitro Transcription facilitates solid-phase IVT of cell-free mRNA, enabling the reuse of the DNA template up to six times. This innovation not only streamlines the plasmid creation process but also enhances mRNA yield on scales ranging from grams to grams. Consequently, it supports the development of a streamlined pipeline, enabling mRNA firms to expedite the transition from development to commercialization.

Major players in the mRNA synthesis raw materials market are actively engaged in the development of raw materials to boost their profitability and market share. Innovations in raw materials and their quality play a pivotal role in enhancing the efficiency, yield, and safety of mRNA synthesis processes, thereby influencing the overall success of applications in biotechnology and medicine. As an instance, in September 2022, TriLink BioTechnologies, a prominent US-based biotechnology company, introduced N1-Methyl-Pseudouridine-5'-Triphosphate, a crucial raw material in the production of various mRNA drugs. This innovative product facilitates accelerated drug discovery, meeting the rising demand for N1-methyl-pseudouridine modified mRNA. TriLink BioTechnologies' commitment to providing unmatched analytical capabilities and GMP-grade offerings underscores its dedication to advancing groundbreaking mRNA-based therapies globally.

In January 2022, Maravai LifeSciences, a United States-centered life sciences enterprise, completed the acquisition of MyChem for $240 million. This strategic acquisition is geared towards enhancing Maravai LifeSciences' array of nucleic acid production offerings and expediting its research and development capacities. MyChem, a company situated in the US, specializes in the manufacturing of nucleotides, making this acquisition a significant move for Maravai's expansion within this sector.

Major companies operating in the messenger ribonucleic acid (mrna) synthesis raw materials market report are Pfizer Inc., F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Moderna Inc, Agilent Technologies Inc., Lonza Group Ltd., Eurofins Scientific, Bio-Rad Laboratories Inc., Qiagen N.V., Maravai LifeSciences, Takara Bio Inc., GenScript Biotech Corporation, Promega Corporation, Abcam plc, BioLegend Inc., Integrated DNA Technologies Inc., Sino Biological Inc., CureVac N.V., LGC Biosearch Technologies, Enzo Biochem Inc, Merck KGaA, GeneCopoeia Inc., Bio-Synthesis Inc., BOC Sciences Inc, Bio Basic Inc., OriGene Technologies Inc., BioCat GmbH, Creative Biogene, Jena Bioscience GmbH, ATDBio Ltd.

North America was the largest region in the mRNA synthesis raw materials market in 2023. The regions covered in the messenger ribonucleic acid (mrna) synthesis raw materials market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the messenger ribonucleic acid (mrna) synthesis raw materials market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

The mRNA synthesis raw materials market consists of sales of modified ribonucleoside triphosphates, polynucleotide tails, ribonucleoside diphosphate (NDPs), ribonucleoside monophosphate (NMPs), and ribonucleoside triphosphate (NTTs). Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on messenger ribonucleic acid (mrna) synthesis raw materials market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for messenger ribonucleic acid (mrna) synthesis raw materials ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The messenger ribonucleic acid (mrna) synthesis raw materials market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

  • 1) By Type: Capping Agents; Nucleotides; Plasmid DNA; Other Types
  • 2) By Applications: Therapeutics Production; Vaccine Production; Other Applications
  • 3) By End-Users: Biotechnology Companies; Pharmaceutical Companies; Research And Academic Institutions; Other End-Users
  • Companies Mentioned: Pfizer Inc.; F. Hoffmann-La Roche AG; Thermo Fisher Scientific Inc.; Moderna Inc; Agilent Technologies Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. mRNA Synthesis Raw Materials Market Characteristics

3. mRNA Synthesis Raw Materials Market Trends And Strategies

4. mRNA Synthesis Raw Materials Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global mRNA Synthesis Raw Materials Market Size and Growth

  • 5.1. Global mRNA Synthesis Raw Materials Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global mRNA Synthesis Raw Materials Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global mRNA Synthesis Raw Materials Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. mRNA Synthesis Raw Materials Market Segmentation

  • 6.1. Global mRNA Synthesis Raw Materials Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Capping Agents
  • Nucleotides
  • Plasmid DNA
  • Other Types
  • 6.2. Global mRNA Synthesis Raw Materials Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Therapeutics Production
  • Vaccine Production
  • Other Applications
  • 6.3. Global mRNA Synthesis Raw Materials Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Biotechnology Companies
  • Pharmaceutical Companies
  • Research And Academic Institutions
  • Other End-Users

7. mRNA Synthesis Raw Materials Market Regional And Country Analysis

  • 7.1. Global mRNA Synthesis Raw Materials Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global mRNA Synthesis Raw Materials Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific mRNA Synthesis Raw Materials Market

  • 8.1. Asia-Pacific mRNA Synthesis Raw Materials Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific mRNA Synthesis Raw Materials Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific mRNA Synthesis Raw Materials Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific mRNA Synthesis Raw Materials Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China mRNA Synthesis Raw Materials Market

  • 9.1. China mRNA Synthesis Raw Materials Market Overview
  • 9.2. China mRNA Synthesis Raw Materials Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China mRNA Synthesis Raw Materials Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China mRNA Synthesis Raw Materials Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India mRNA Synthesis Raw Materials Market

  • 10.1. India mRNA Synthesis Raw Materials Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India mRNA Synthesis Raw Materials Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India mRNA Synthesis Raw Materials Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan mRNA Synthesis Raw Materials Market

  • 11.1. Japan mRNA Synthesis Raw Materials Market Overview
  • 11.2. Japan mRNA Synthesis Raw Materials Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan mRNA Synthesis Raw Materials Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan mRNA Synthesis Raw Materials Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia mRNA Synthesis Raw Materials Market

  • 12.1. Australia mRNA Synthesis Raw Materials Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia mRNA Synthesis Raw Materials Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia mRNA Synthesis Raw Materials Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia mRNA Synthesis Raw Materials Market

  • 13.1. Indonesia mRNA Synthesis Raw Materials Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia mRNA Synthesis Raw Materials Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia mRNA Synthesis Raw Materials Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea mRNA Synthesis Raw Materials Market

  • 14.1. South Korea mRNA Synthesis Raw Materials Market Overview
  • 14.2. South Korea mRNA Synthesis Raw Materials Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea mRNA Synthesis Raw Materials Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea mRNA Synthesis Raw Materials Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe mRNA Synthesis Raw Materials Market

  • 15.1. Western Europe mRNA Synthesis Raw Materials Market Overview
  • 15.2. Western Europe mRNA Synthesis Raw Materials Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe mRNA Synthesis Raw Materials Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe mRNA Synthesis Raw Materials Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK mRNA Synthesis Raw Materials Market

  • 16.1. UK mRNA Synthesis Raw Materials Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK mRNA Synthesis Raw Materials Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK mRNA Synthesis Raw Materials Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany mRNA Synthesis Raw Materials Market

  • 17.1. Germany mRNA Synthesis Raw Materials Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany mRNA Synthesis Raw Materials Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany mRNA Synthesis Raw Materials Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France mRNA Synthesis Raw Materials Market

  • 18.1. France mRNA Synthesis Raw Materials Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France mRNA Synthesis Raw Materials Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France mRNA Synthesis Raw Materials Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy mRNA Synthesis Raw Materials Market

  • 19.1. Italy mRNA Synthesis Raw Materials Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy mRNA Synthesis Raw Materials Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy mRNA Synthesis Raw Materials Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain mRNA Synthesis Raw Materials Market

  • 20.1. Spain mRNA Synthesis Raw Materials Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain mRNA Synthesis Raw Materials Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain mRNA Synthesis Raw Materials Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe mRNA Synthesis Raw Materials Market

  • 21.1. Eastern Europe mRNA Synthesis Raw Materials Market Overview
  • 21.2. Eastern Europe mRNA Synthesis Raw Materials Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe mRNA Synthesis Raw Materials Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe mRNA Synthesis Raw Materials Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia mRNA Synthesis Raw Materials Market

  • 22.1. Russia mRNA Synthesis Raw Materials Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia mRNA Synthesis Raw Materials Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia mRNA Synthesis Raw Materials Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America mRNA Synthesis Raw Materials Market

  • 23.1. North America mRNA Synthesis Raw Materials Market Overview
  • 23.2. North America mRNA Synthesis Raw Materials Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America mRNA Synthesis Raw Materials Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America mRNA Synthesis Raw Materials Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA mRNA Synthesis Raw Materials Market

  • 24.1. USA mRNA Synthesis Raw Materials Market Overview
  • 24.2. USA mRNA Synthesis Raw Materials Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA mRNA Synthesis Raw Materials Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA mRNA Synthesis Raw Materials Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada mRNA Synthesis Raw Materials Market

  • 25.1. Canada mRNA Synthesis Raw Materials Market Overview
  • 25.2. Canada mRNA Synthesis Raw Materials Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada mRNA Synthesis Raw Materials Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada mRNA Synthesis Raw Materials Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America mRNA Synthesis Raw Materials Market

  • 26.1. South America mRNA Synthesis Raw Materials Market Overview
  • 26.2. South America mRNA Synthesis Raw Materials Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America mRNA Synthesis Raw Materials Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America mRNA Synthesis Raw Materials Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil mRNA Synthesis Raw Materials Market

  • 27.1. Brazil mRNA Synthesis Raw Materials Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil mRNA Synthesis Raw Materials Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil mRNA Synthesis Raw Materials Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East mRNA Synthesis Raw Materials Market

  • 28.1. Middle East mRNA Synthesis Raw Materials Market Overview
  • 28.2. Middle East mRNA Synthesis Raw Materials Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East mRNA Synthesis Raw Materials Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East mRNA Synthesis Raw Materials Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa mRNA Synthesis Raw Materials Market

  • 29.1. Africa mRNA Synthesis Raw Materials Market Overview
  • 29.2. Africa mRNA Synthesis Raw Materials Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa mRNA Synthesis Raw Materials Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa mRNA Synthesis Raw Materials Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. mRNA Synthesis Raw Materials Market Competitive Landscape And Company Profiles

  • 30.1. mRNA Synthesis Raw Materials Market Competitive Landscape
  • 30.2. mRNA Synthesis Raw Materials Market Company Profiles
    • 30.2.1. Pfizer Inc.
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. F. Hoffmann-La Roche AG
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Thermo Fisher Scientific Inc.
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Moderna Inc
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Agilent Technologies Inc.
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. mRNA Synthesis Raw Materials Market Other Major And Innovative Companies

  • 31.1. Lonza Group Ltd.
  • 31.2. Eurofins Scientific
  • 31.3. Bio-Rad Laboratories Inc.
  • 31.4. Qiagen N.V.
  • 31.5. Maravai LifeSciences
  • 31.6. Takara Bio Inc.
  • 31.7. GenScript Biotech Corporation
  • 31.8. Promega Corporation
  • 31.9. Abcam plc
  • 31.10. BioLegend Inc.
  • 31.11. Integrated DNA Technologies Inc.
  • 31.12. Sino Biological Inc.
  • 31.13. CureVac N.V.
  • 31.14. LGC Biosearch Technologies
  • 31.15. Enzo Biochem Inc

32. Global mRNA Synthesis Raw Materials Market Competitive Benchmarking

33. Global mRNA Synthesis Raw Materials Market Competitive Dashboard

34. Key Mergers And Acquisitions In The mRNA Synthesis Raw Materials Market

35. mRNA Synthesis Raw Materials Market Future Outlook and Potential Analysis

  • 35.1 mRNA Synthesis Raw Materials Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 mRNA Synthesis Raw Materials Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 mRNA Synthesis Raw Materials Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer